Titlebook: Kazakhstan‘s Diversification from the Natural Resources Sector; Strategic and Econom Irina Heim Book 2020 The Editor(s) (if applicable) and

強(qiáng)制令

Chinese Investments Across the New Silk Road as future perspectives. It reviews recent projects such as the world’s biggest “dry port” at the border between China and Kazakhstan. The chapter explores why China is seeking new ground for economic growth and therefore intends to build a much closer bilateral relationship with other countries, en

黑豹

Kazakhstan as Logistics Linchpin in the Belt and Road Initiative Kazakhstan’s geographic position, political stability, relatively high per capita income, highly developed energy sector and the fact that the old Silk Road ran along Kazakhstan’s southern border has catalyzed development of an integrated transport complex where logistics, air transportation and fi

光滑

Diversification and Local Industry Developmentent from the three largest projects in Kazakhstan, the research finds that a significant part of the goods purchased by operators for the development of oil and gas deposits are products of high technology production. Such goods are mostly imported, and the products most often purchased from local s

Externalize

Building Entrepreneurial Ecosystems: Effects of Economic Integrationonnecting technologies, the authors consider, in the first instance, how economic integration may affect small and medium-sized enterprises (SMEs). The chapter explores the case of the Eurasian Economic Union (EEA). It argues that the understanding of economic integration trends is essential for cou

dissolution

貧窮地活

te multiple signaling pathways in unique combinations; that is, one drug can be an agonist at pathway A and an antagonist or partial agonist at pathway B, and another drug can have the reverse profile. Functional selectivity has profound implications for drug development, for chemical biology, and f

Limerick

APRON

PATRI

Irina Heim,Maxim Romanovmbinations; that is, one drug can be an agonist at pathway A and an antagonist or partial agonist at pathway B, and another drug can have the reverse profile. Functional selectivity has profound implications for drug development, for chemical biology, and for the design of experiments to characteriz

monologue